Corine de Jong

5PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 21, 2023
Association between Genetic Variants and Peripheral Neuropathy in Patients with NSCLC Treated with First-Line Platinum-Based Therapy.

Corine de Jong, Gerarda J M Herder, Simone W A van Haarlem

|Mar 18, 2022
The association between skeletal muscle measures and chemotherapy-induced toxicity in non-small cell lung cancer patients.

Corine de Jong, Najiba Chargi, Gerarda J M Herder

|Nov 27, 2021
Association between Genetic Variants and Cisplatin-Induced Nephrotoxicity: A Genome-Wide Approach and Validation Study.

Zulfan Zazuli, Corine de Jong, Wei Xu

|Oct 19, 2020
Genetic variants as predictors of toxicity and response in patients with non-small cell lung cancer undergoing first-line platinum-based chemotherapy: Design of the multicenter PGxLUNG study.

Corine de Jong, Gerarda J M Herder, Vera H M Deneer

|May 09, 2020
Association between serum biomarkers CEA and LDH and response in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.

Corine de Jong, Vera H M Deneer, Johannes C Kelder

Pageof 1

Frequent Collaborators

4 joint publications

Toine C G Egberts

3 joint publications

Vera H M Deneer

1 joint publications

Johannes C Kelder

1 joint publications

Zulfan Zazuli